Cardiac resynchronization therapy (CRT) has been shown to improve quality-of-life, functional status, exercise capacity, and survival in patients with left ventricular systolic dysfunction, moderate to severe heart failure symptoms, and a wide QRS. Controlled, randomized CRT trials have used atrial sensing to provide atrial-synchronized biventricular pacing, but have not focused on atrial pacin...